Correction

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer (vol 30, pg 297, 2019)

Journal

ANNALS OF ONCOLOGY
Volume 30, Issue 10, Pages 1673-1673

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdz171

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available